Human Chorionic Gonadotropin (HCG) Market Is Anticipated To Reach US$ 710.88 Million In 2022 And Grow At A 6.5% CAGR During The Forecast Period (2022-2030)

Human Chorionic Gonadotropin (HCG) Market
Human Chorionic Gonadotropin (HCG) Market

Human chorionic gonadotropin hormone (HCG), a hormone, is secreted by the placenta after a fertilised zygote implants in the uterus. HCG stimulates the release of eggs from the ovary and supports the development of eggs normally. In the course of treating infertility, the HCG triggers ovulation in females and boosts sperm counts in males. Human chorionic gonadotropin (HCG), a chemical commonly present in early embryos, is produced by trophoblast tissue.

The technology, therapeutic area, end user, and geographic regions are used to segment the global Human Chorionic Gonadotropin (HCG) Market. Recombinant technology and natural source extraction are the two technological divisions of the market. It is divided into treatments for male hypogonadism, oligospermia, and female infertility, among other therapeutic areas. It is divided into fertility clinics, research institutions, and other categories depending on the end user. It is examined across North America, Europe, Asia-Pacific, and LAMEA based on region.

During the projected period, an increase in the prevalence of illnesses connected to hypogonadism is anticipated to fuel market expansion. During the projected period, an increase in the prevalence of illnesses connected to hypogonadism is anticipated to fuel Human Chorionic Gonadotropin (HCG) Market Expansion. For instance, according to the Endocrine Society (January 2022), hypogonadism is a disorder that affects many men worldwide, with older men, obese men, and men with type 2 diabetes having a higher prevalence than other men.

The primary element fueling market expansion is the rise in male hypogonadism among the senior population. Additionally, Human Chorionic Gonadotropin (HCG) Market growing popularity among patients and medical professionals would support market expansion. However, the FDA's cautions and warnings about the adverse consequences of hCG therapy are anticipated to restrain market expansion. Additionally, undeveloped economies are expected to present profitable chances for the growth of the hCG industry.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030